Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06449430Recruiting
Randomised, open-label trial of propofol in breech presentation (2 arms), sponsored by Fundación para la Formación e Investigación Sanitaria. Primary endpoint: Success rate of external cephalic version up to 24 months. Started Jul 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06449430.